List of BioNTech patents

Patents where

Current Assignee

Name

BioNTech

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9267177 Identification of tumor-associated cell surface antigens for diagnosis and therapy	Patent 9267177 was granted and assigned to BioNTech on February, 2016 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9267177	February 23, 2016
‌ US Patent 9321808 Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers	Patent 9321808 was granted and assigned to BioNTech on April, 2016 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	9321808	April 26, 2016
‌ US Patent 9533043 Identification of surface-associated antigens for tumor diagnosis and therapy	Patent 9533043 was granted and assigned to BioNTech on January, 2017 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9533043	January 3, 2017
‌ US Patent 9476055 Modification of RNA, producing an increased transcript stability and translation efficiency	Patent 9476055 was granted and assigned to BioNTech on October, 2016 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	9476055	October 25, 2016
‌ US Patent 9194004 Identification of surface-associated antigens for tumor diagnosis and therapy	Patent 9194004 was granted and assigned to BioNTech on November, 2015 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9194004	November 24, 2015
‌ US Patent 10106800 Modification of RNA, producing an increased transcript stability and translation efficiency	Patent 10106800 was granted and assigned to BioNTech on October, 2018 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	10106800	October 23, 2018
‌ US Patent 9175088 Identification of tumor-associated markers for diagnosing or monitoring ovarian cancer	Patent 9175088 was granted and assigned to BioNTech on November, 2015 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	9175088	November 3, 2015
‌ US Patent 10253373 Identification of tumor-associated markers for diagnosis and therapy	Patent 10253373 was granted and assigned to BioNTech on April, 2019 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	10253373	April 9, 2019
‌ US Patent 9730976 Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers	Patent 9730976 was granted and assigned to BioNTech on August, 2017 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	9730976	August 15, 2017
‌ US Patent 10302647 Identification of surface-associated antigens for tumor diagnosis and therapy	Patent 10302647 was granted and assigned to BioNTech on May, 2019 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	10302647	May 28, 2019
‌ US Patent 11020477 RNA vaccines	Patent 11020477 was granted and assigned to BioNTech on June, 2021 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	11020477	June 1, 2021
‌ US Patent 10370433 Compositions and methods for diagnosis and treatment of cancer	Patent 10370433 was granted and assigned to BioNTech on August, 2019 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	10370433	August 6, 2019
‌ US Patent 8980265 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)	Patent 8980265 was granted and assigned to BioNTech on March, 2015 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	8980265	March 17, 2015
‌ US Patent 9637794 Genetic products differentially expressed in tumors and use thereof	Patent 9637794 was granted and assigned to BioNTech on May, 2017 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9637794	May 2, 2017
‌ US Patent 9910043 Identification of tumor-associated cell surface antigens for diagnosis and therapy	Patent 9910043 was granted and assigned to BioNTech on March, 2018 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9910043	March 6, 2018
‌ US Patent 8637006 Recombinant vaccines and use thereof	Patent 8637006 was granted and assigned to BioNTech on January, 2014 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	8637006	January 28, 2014
‌ US Patent 8178653 Recombinant vaccines and use thereof	Patent 8178653 was granted and assigned to BioNTech on May, 2012 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	8178653	May 15, 2012
‌ US Patent 9139880 Identification of tumor-associated cell surface antigens for diagnosis and therapy	Patent 9139880 was granted and assigned to BioNTech on September, 2015 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9139880	September 22, 2015
‌ US Patent 10172960 Particles comprising single stranded RNA and double stranded RNA for immunomodulation	Patent 10172960 was granted and assigned to BioNTech on January, 2019 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	10172960	January 8, 2019
‌ US Patent 9636414 Particles comprising single stranded RNA and double stranded RNA for immunomodulation	Patent 9636414 was granted and assigned to BioNTech on May, 2017 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	9636414	May 2, 2017
‌ US Patent 9944708 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)	Patent 9944708 was granted and assigned to BioNTech on April, 2018 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	9944708	April 17, 2018
‌ US Patent 10980875 Cytotoxic immunostimulating particles and uses thereof	Patent 10980875 was granted and assigned to BioNTech on April, 2021 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	10980875	April 20, 2021
‌ US Patent 8278262 Use of microproteins as tryptase inhibitors	Patent 8278262 was granted and assigned to BioNTech on October, 2012 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	8278262	October 2, 2012
‌ US Patent 10626400 Stabilised formulations of RNA	Patent 10626400 was granted and assigned to BioNTech on April, 2020 by the United States Patent and Trademark Office.	BioNTech	BioNTech	United States Patent and Trademark Office	10626400	April 21, 2020
‌ US Patent 8840902 Tumor vaccination involving a humoral immune response against self-proteins	Patent 8840902 was granted and assigned to BioNTech on September, 2014 by the United States Patent and Trademark Office.		BioNTech	United States Patent and Trademark Office	8840902	September 23, 2014

Results per page:

27 results

0 selected

27 results

0 selected